Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes
Year: 2018
Type: article
Abstract: It has been posited that anti-tumoral innate activation is driven by derepression of endogenous repeats. We compared RNA sequencing protocols to assess repeat transcriptomes in The Cancer Genome Atlas (TCGA). Although poly(A) selection efficiently detects coding genes, most non-coding genes, and limited subsets of repeats, it fails to capture overall repeat expression and co-expression. Alternatively, total RNA expression reveals distinct repeat co-expression subgroups and delivers greater dynamic changes, implying they may serve as better biomarkers of clinical outcomes. We show that endogenous retrovirus expression predicts immunotherapy response better than conventional immune signatures in one cohort yet is not predictive in another. Moreover, we find that global repeat derepression, including the HSATII satellite repeat, correlates with an immunosuppressive phenotype in colorectal and pancreatic tumors and validate in situ . In conclusion, we stress the importance of analyzing the full spectrum of repeat transcription to decode their role in tumor immunity.
Source: Cell Reports
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,620
Funders: National Science Foundation, Burroughs Wellcome Fund, Bristol-Myers Squibb Foundation, V Foundation for Cancer Research, Bristol-Myers Squibb, AstraZeneca, Merck, Melanoma Research Alliance, Lustgarten Foundation, Ludwig Institute for Cancer Research, National Institutes of Health, Genentech, Stand Up To Cancer, National Cancer Institute, National Institute of Allergy and Infectious Diseases
OpenAlex ID: W2620917552
